Blue Water Life Science Advisors, LP

CIK 0001789778 · LARKSPUR, CA · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source

Blue Water Life Science Advisors, LP reported 9 positions worth $158.8M as of June 30, 2026 (13F filed August 14, 2026). Largest holding: CDNA (21.4%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$158.8M
2026 Q2
Positions
9
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
100.0%
Est. Net Flow (Q)
2026 Q2
9 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1CDNACAREDX INCSH$33.9M21.36%1,190,000
2TXG10X GENOMICS INCSH$24.6M15.50%642,000
3PSNLPERSONALIS INCSH$22.5M14.15%1,676,300
4ADPTADAPTIVE BIOTECHNOLOGIES CORSH$21.7M13.65%1,010,145
5GHGUARDANT HEALTH INCSH$17.2M10.84%114,747
6QTRXQUANTERIX CORPSH$15.0M9.45%3,474,202
7NTRANATERA INCSH$9.4M5.90%34,494
8BLLNBILLIONTOONE INCSH$8.4M5.29%70,000
9TEMTEMPUS AI INCSH$6.1M3.85%105,412

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does Blue Water Life Science Advisors, LP hold as of Q2 2026?

Blue Water Life Science Advisors, LP reported 9 positions worth $158.8M in its Q2 2026 13F filing. Largest positions: CDNA (21.4%), TXG (15.5%), PSNL (14.1%), ADPT (13.6%) and GH (10.8%).

What did Blue Water Life Science Advisors, LP buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Blue Water Life Science Advisors, LP sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.